Zobrazeno 1 - 10
of 54
pro vyhledávání: '"W. M. Drake"'
Publikováno v:
The Journal of clinical endocrinology and metabolism.
Cabergoline is first line treatment for most patients with lactotrope pituitary tumors and hyperprolactinemia. Its use at high-dose in Parkinson's disease has largely been abandoned, because of its association with the development of a characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57211315a2557ca897dd9e1117291431
https://pubmed.ncbi.nlm.nih.gov/30933294
https://pubmed.ncbi.nlm.nih.gov/30933294
Publikováno v:
QJM : monthly journal of the Association of Physicians. 110(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7f8ce00f472e3abea10614aab643df
https://pubmed.ncbi.nlm.nih.gov/28666340
https://pubmed.ncbi.nlm.nih.gov/28666340
Autor:
S. Bhattacharya, S.J. Edmondson, Umasuthan Srirangalingam, Robert Carpenter, Kirun Gunganah, W. M. Drake
Publikováno v:
EJVES Short Reports, Vol 35, Iss, Pp 1-6 (2017)
EJVES Short Reports
EJVES Short Reports
Objective/background Phaeochromocytomas and paragangliomas are vascular neuroendocrine tumours distributed between the neck and the pelvis and may be associated with catecholamine secretion. The aim of the study was to describe the complex surgical m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e0cc09e172fdabafd803fc67fa78d7
Different etiologies of hypopituitarism may give rise to distinct patterns of hormone deficiency, all causes may eventually lead to panhypopituitarism. Typically, pituitary tumors lead to gradual loss of anterior pituitary hormones with disinhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f8e045ea37db3be303a84330baf2322
https://doi.org/10.1016/b978-0-12-801238-3.95970-1
https://doi.org/10.1016/b978-0-12-801238-3.95970-1
Autor:
Craig E Stiles, Richard P. Steeds, Josh Bevan, Andrew A. Toogood, W. M. Drake, Trevor A. Howlett
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:90-96
Concern exists in the literature that the long-term use of ergot-derived dopamine agonist drugs for the treatment of hyperprolactinemia may be associated with clinically significant valvular heart disease.The aim of the study was to determine the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::792fd8b5de583185c69cd45266d1a7c2
https://doi.org/10.1210/jc.2013-2254
https://doi.org/10.1210/jc.2013-2254
Autor:
Anju Sahdev, Mark J Hannon, Mona Waterhouse, Matthew Matson, W. M. Drake, Laila Parvanta, Wing-Chiu Sze, Robert Carpenter, Daniel M. Berney, Scott Akker, Maralyn Druce
Publikováno v:
QJM : monthly journal of the Association of Physicians. 110(5)
Background: In approximately half of cases of primary aldosteronism (PA), the cause is a surgically-resectable unilateral aldosterone-producing adrenal adenoma (APA). However, long-term data on surgical outcomes are sparse. Aim: We report on clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eaca72cfa08447bcd97659cc796d0ac
https://pubmed.ncbi.nlm.nih.gov/28180906
https://pubmed.ncbi.nlm.nih.gov/28180906
Autor:
Andrew Markey, Marian Lanyon, Mark Vanderpump, Narenda Lakshmana Reddy, Gordon T. Plant, Michael Powell, John A.H. Wass, W. M. Drake, Senthil Rajasekaran, Saurabh Sinha, Stephanie E Baldeweg
Publikováno v:
Clinical Endocrinology. 74:9-20
Classical pituitary apoplexy is a medical emergency and rapid replacement with hydrocortisone maybe life saving. It is a clinical syndrome characterized by the sudden onset of headache, vomiting, visual impairment and decreased consciousness caused b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f33ed017ebfa07fb30338b420770ef0
https://doi.org/10.1111/j.1365-2265.2010.03913.x
https://doi.org/10.1111/j.1365-2265.2010.03913.x
Autor:
Adrian J. L. Clark, John P. Monson, W. M. Drake, D. M. Walker, S Owusu-Antwi, Scott Akker, Veronica Moyes, Louise A. Metherell, K. T. Maher
Publikováno v:
Clinical Endocrinology. 72:807-813
Summary Objective Heterogeneity in growth hormone (GH) responsiveness in adult hypopituitary patients receiving recombinant human GH (rhGH) is poorly understood; doses vary up to fourfold between individuals. Deletion of exon 3 in the GH receptor (d3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21cbec1a18e44d49e86d7fd171f9a477
https://doi.org/10.1111/j.1365-2265.2009.03768.x
https://doi.org/10.1111/j.1365-2265.2009.03768.x
Autor:
Ashley B. Grossman, P. N. Plowman, Francesca Swords, John R. T. Monson, G. M. Besser, S. L. Chew, W M Drake
Publikováno v:
European Journal of Endocrinology. 161:819-828
ObjectiveWe report the use of ‘gamma knife’ (GK) radiosurgery in 25 patients with pituitary adenomas not cured despite conventional therapy, including external beam radiotherapy.Patients and methodsAll patients had previously received conventiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::394ea3e97ee724789a7e3ccde6389c81
https://doi.org/10.1530/eje-09-0493
https://doi.org/10.1530/eje-09-0493
Publikováno v:
European Journal of Endocrinology. 159:541-545
BackgroundCabergoline is a dopamine agonist that may be used as primary or adjunctive therapy for acromegaly. Although one study suggested biochemical control may be achieved in a substantial proportion of patients, it is still commonly perceived to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a64a7c445ada239d15fa04de370f4d0
https://doi.org/10.1530/eje-08-0306
https://doi.org/10.1530/eje-08-0306